CNTX Stock Price | Context Therapeutics Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

By MarketWatch | Jun 24, 2024 at 04:04 PM EST

Context Therapeutics, Inc. is focused on developing innovative treatments for hormone-driven breast and gynecological cancers. Their lead candidate, ONA-XR, aims to be a complete antagonist of the progesterone receptor. Founded in 2015, the company is headquartered in Philadelphia, PA.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.